ScholarIQanswers from OpenAlex
West Cancer Center
InstitutionResearch output, impact & collaborations
West Cancer Center is a institution indexed in ScholarIQ from OpenAlex.
What is known about West Cancer Center?
ScholarIQrecord summary
West Cancer Center is a research organisation in Germantown, US. OpenAlex records 1,978 works and 108,699 citations for it. 421 researchers list it as their most recent affiliation.
How many works does West Cancer Center have?
ScholarIQindexed works
West Cancer Center has 1,978 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does West Cancer Center have?
ScholarIQcitation count
West Cancer Center has 108,699 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at West Cancer Center?
ScholarIQresearcher count
West Cancer Center has 421 researchers in the ScholarIQ index.
What is the average h-index at West Cancer Center?
ScholarIQavg h-index
West Cancer Center has an average h-index of 0 in OpenAlex.
What is the ROR of West Cancer Center?
ScholarIQror
The ROR for West Cancer Center is on the source record.
What is the OpenAlex record for West Cancer Center?
ScholarIQopenalex
The OpenAlex for West Cancer Center is on the source record.
Who are the most-cited researchers behind West Cancer Center?
ScholarIQtop researchers by citations
What are the most-cited papers on West Cancer Center?
ScholarIQmost cited works
SEZ6 expression and lineage plasticity in small cell lung cancer and transformed non-small cell lung cancer
Jennifer A. Marks, Kieran Sweeney, Andrew Elliott, Brinda Gupta, Ari VanderWalde, Sonam Puri, Misty Dawn Shields, Jorge J. Nieva, Heloisa Resende SOARES, Patrick C. Ma, Balázs Halmos, Stephen V. Liu
Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient Cohort
George Nassief, Tolulope Adeyelu, Andrew Elliott, Jordan Phillipps, Renée Morecroft, Alice Y. Zhou, Peter W. Szlosarek, Caroline Robert, Farah Abdulla, Ari VanderWalde, Soo J. Park, D. Chen, G. Ansstas
OA02.01: Unveiling Novel Drivers of MHC Repression and Therapeutic Strategies to Counter Immune Evasion in Small Cell Lung Cancer
Triparna Sen, Subhamoy Chakraborty, Andrew Elliott, Vrinda Jethalia, Ari VanderWalde, Balazs Halmos, Deniz Demircioglu, Dan Hasson
Safety and feasibility of intratumoral injection of RP1 or RP2 oncolytic immunotherapies in visceral metastases.
Caroline Robert, Tawnya L. Bowles, Mark R. Middleton, Judith Michels, Miguel F. Sanmamed, Ari VanderWalde, Jiaxin Niu, Caroline Gaudy‐Marqueste, Eva Muñoz‐Couselo, Gino K. In, M. De Miguel, Andres Cervantes, Georgia Beasley, Tim Liu, Kumiko Yanase, Chris Tucci, Danielle Ulanet, Jeannie W Hou, Gary Vanasse, Mohammed Milhem
PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer
Mihaela Aldea, Daniela Espósito, Meghanne Lomibao, Arianna Marinello, Adeyelu Tolulope, Helena Bote-de Cabo, Gheorghe Emilian Olteanu, Jamie Feng, Alessandro Di Federico, M. Duruisseaux, Massimiliano Cani, Daniela Miliziano, Francesca Colamartini, Barliz Waissengrin, Fabrizio Citarella, Teresa Gorría, Isabelle Monnet, Anna Eisert, Emilio Bria, P. Iranzo, Mariana Brandão, Florian Guisier, Xinan Wang, Maisam Makarem, Fabiana Napolitano, Colin R. Lindsay, Giovanna Attanasio, Christina Falcon, Vladmir Cordeiro de Lima, Amin H. Nassar, Judith Raimbourg, N. Minatta, Elizabeth Fabre, Ayesha Aijaz, Abdul Rafeh Naqash, Sophie Cousin, Katarzyna Szymczak, Alessandro Russo, Vincent Fallet, Clarisse Audigier-Valette, H. Doubre, Nicolas Girard, Philippe Rochigneux, Annarita Avanzo, Francesco Cortiula, José Carlos Benítez, A Calles, Marco Tagliamento, Arianna Pagliaro, D. Cortinovis, A. Stemmer, Alberto Servetto, Giannis Mountzios, Jordi Remon, Ari VanderWalde, Andrew Elliott, Alessio Cortellini, Balazs Halmos, Luigi Formisano, Fabrice Barlesi, Karen L. Reckamp, Diana N. Ionescu, Frances A. Shepherd, Pasi A. Jänne, David Planchard, Roberto Bianco, Alexander Drilon, Julia Rotow, Benjamin Besse
How much of the research on West Cancer Center is open access?
ScholarIQopen access share
40%OPEN ACCESS